🎉 M&A multiples are live!
Check it out!

IBA Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for IBA Group and similar public comparables like Myomo, SmartVest, and Philips.

IBA Group Overview

About IBA Group

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World.


Founded

1986

HQ

Belgium
Employees

2.0K+

Financials

LTM Revenue $546M

LTM EBITDA $36.3M

EV

$321M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

IBA Group Financials

IBA Group has a last 12-month revenue of $546M and a last 12-month EBITDA of $36.3M.

In the most recent fiscal year, IBA Group achieved revenue of $460M and an EBITDA of $13.5M.

IBA Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See IBA Group valuation multiples based on analyst estimates

IBA Group P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $388M $460M XXX XXX XXX
Gross Profit $116M $136M XXX XXX XXX
Gross Margin 30% 30% XXX XXX XXX
EBITDA $13.3M $13.5M XXX XXX XXX
EBITDA Margin 3% 3% XXX XXX XXX
Net Profit $4.2M $6.5M XXX XXX XXX
Net Margin 1% 1% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

IBA Group Stock Performance

As of April 15, 2025, IBA Group's stock price is EUR 10 (or $11).

IBA Group has current market cap of EUR 300M (or $322M), and EV of EUR 299M (or $321M).

See IBA Group trading valuation data

IBA Group Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$321M $322M XXX XXX XXX XXX $0.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

IBA Group Valuation Multiples

As of April 15, 2025, IBA Group has market cap of $322M and EV of $321M.

IBA Group's trades at 0.6x LTM EV/Revenue multiple, and 8.8x LTM EBITDA.

Analysts estimate IBA Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for IBA Group and 10K+ public comps

IBA Group Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $321M XXX XXX XXX
EV/Revenue 0.7x XXX XXX XXX
EV/EBITDA 23.9x XXX XXX XXX
P/E -32.9x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -9.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get IBA Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

IBA Group Valuation Multiples

IBA Group's NTM/LTM revenue growth is 18%

IBA Group's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, IBA Group's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate IBA Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for IBA Group and other 10K+ public comps

IBA Group Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 19% XXX XXX XXX XXX
EBITDA Margin 3% XXX XXX XXX XXX
EBITDA Growth 2% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 21% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 6% XXX XXX XXX XXX
G&A Expenses to Revenue 13% XXX XXX XXX XXX
R&D Expenses to Revenue 11% XXX XXX XXX XXX
Opex to Revenue 30% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

IBA Group Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

IBA Group M&A and Investment Activity

IBA Group acquired  XXX companies to date.

Last acquisition by IBA Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . IBA Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by IBA Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About IBA Group

When was IBA Group founded? IBA Group was founded in 1986.
Where is IBA Group headquartered? IBA Group is headquartered in Belgium.
How many employees does IBA Group have? As of today, IBA Group has 2.0K+ employees.
Who is the CEO of IBA Group? IBA Group's CEO is Mr. Olivier Legrain.
Is IBA Group publicy listed? Yes, IBA Group is a public company listed on BRU.
What is the stock symbol of IBA Group? IBA Group trades under IBAB ticker.
When did IBA Group go public? IBA Group went public in 1998.
Who are competitors of IBA Group? Similar companies to IBA Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of IBA Group? IBA Group's current market cap is $322M
What is the current revenue of IBA Group? IBA Group's last 12-month revenue is $546M.
What is the current EBITDA of IBA Group? IBA Group's last 12-month EBITDA is $36.3M.
What is the current EV/Revenue multiple of IBA Group? Current revenue multiple of IBA Group is 0.6x.
What is the current EV/EBITDA multiple of IBA Group? Current EBITDA multiple of IBA Group is 8.8x.
What is the current revenue growth of IBA Group? IBA Group revenue growth between 2023 and 2024 was 19%.
Is IBA Group profitable? Yes, IBA Group is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.